Ignite Creation Date:
2025-12-25 @ 4:31 AM
Ignite Modification Date:
2026-04-15 @ 1:33 AM
Study NCT ID:
NCT04722718
Status:
UNKNOWN
Last Update Posted:
2022-04-28
First Post:
2021-01-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Sintilimab and Apatinib Combined Chemotherapy in Breast Cancer
Sponsor:
Jiuda Zhao
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
AHQU-2021003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None